ORMP Oramed Pharma Yalpi foyda bo'yicha rentabellik

oramed.com (ORMP) korporativ emblemasi va logotipi

Oramed Pharmaceuticals inyeksion dori vositalarining oral shakllarini ishlab chiqishdagi o'z vakolatiga tayanadi. GURU.Markets grafigidagi sotilgan tovarlar tannarxi chegirib tashlanganidan keyingi yalpi foyda, joriy metrika qiymati 0.00 bo'lgan holda, moliyaviy dinamikani tasdiqlaydi. Biroq, klinik sinovlarning muvaffaqiyatsizligi sababli kapitalning chiqib ketishi modelning yashab qolishini FDA qarorlariga bog'laydi, biznesning muvaffaqiyati esa tartibga soluvchi organlarning tasdiqlari va patent himoyasiga bog'liq.

Yalpi marja: Oramed Pharmaceuticals (ORMP) 04.07.2022 - 20.11.2026 uchun

Oramed Pharmaceuticals Inc. (ORMP) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:Oramed Pharmaceuticals (ORMP)
oramed.com tomonidan chiqariladigan mahsulotlar

Oramed Pharmaceuticals (ORMP) uchun yalpi foyda marjasi oral insulin ishlab chiqish xarajatlarini boshqarish samaradorligining generatsiya qilingan daromadga nisbatan ko'rsatkichi bo'lib xizmat qiladi. Yalpi foyda marjasi barqarorligini tahlil qilish sotilgan tovarlar tannarxini chegirib tashlagandan keyingi foyda ulushini baholash imkonini beradi, bu esa beqaror kapital oqimlari sharoitida xarajatlarni optimallashtirishga bog'liq holda FDA qarorlarini kutayotgan kompaniyaning yashab qolishi uchun juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|Yalpi foyda bo'yicha sotuv rentabelligi Entera Bio|Yalpi marja HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Yalpi rentabellik|Cumberland Corp - Yalpi marja|QNTM - Yalpi marja|FibroGen, Inc. (FGEN) - Yalpi rentabellik|TELO: Yalpi foyda koeffitsiyenti|RANI (Rani Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi synergychc.com SNYR|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja